Document is current
Any future updates will be listed below
-
Authors
Di Fusco, Manuela https://orcid.org/0000-0003-0079-7331
Cappelleri, Joseph C.
Yehoshua, Alon
Craig, Kelly J. Thomas
Alvarez, Mary B.
Allen, Kristen E.
Porter, Thomas M.
Lopez, Santiago M.C.
Puzniak, Laura
Sun, Xiaowu
-
Funding
Funding for this research was provided by:
Pfizer (Not applicable)
- License Information
-
More Information
Article History
Received: 30 November 2023
Accepted: 9 October 2024
First Online: 22 October 2024
Declarations
:
: This study was approved by the Sterling IRB, Protocol #C4591034. Participation in the study was voluntary and anonymous. Consent was obtained electronically via the CVS Health E-Consent platform. Participants were informed of their right to refuse or withdraw from the study at any time. Participants were compensated for their time.
: All authors provided consent to publish the findings of this study.
: MDC, AY, MBA, KEA, TMP, LP, SMCL, and JCC are employed by Pfizer<sup>®</sup> Inc. and hold stock or stock options of Pfizer. XS and KJTC are employed by CVS Health<sup>®</sup> Corporation and hold stock and receive equity from CVS Health, which received funding from Pfizer in connection with the development of this manuscript.
